Journal:IUCrJ:S2052252522006820

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (13:42, 2 February 2023) (edit) (undo)
 
(27 intermediate revisions not shown.)
Line 1: Line 1:
-
<StructureSection load='' size='450' side='right' scene='underdevelopment' caption=''>
+
<StructureSection load='' size='450' side='right' scene='94/949060/Cv/12' caption=''>
===Organism Specific Differences in Binding of Ketoprofen to Serum Albumin===
===Organism Specific Differences in Binding of Ketoprofen to Serum Albumin===
-
<big>Dr Wladek Minor, Mateusz Czub</big> <ref>doi: 10.1107/S2052252522006820</ref>
+
<big>Mateusz P. Czub, Alan J. Stewart, Ivan G. Shabalin, and Wladek Minor</big> <ref>doi: 10.1107/S2052252522006820</ref>
<hr/>
<hr/>
<b>Molecular Tour</b><br>
<b>Molecular Tour</b><br>
 +
Serum albumin (SA) is the most abundant plasma protein and a transporter of hormones, metal ions, and common metabolites, such as fatty acids and sugars, in the blood<ref name='Doweiko'>doi: 10.1177/0148607191015002207</ref><ref name='Peters'>Peters TJT. All About Albumin: Biochemistry, Genetics, and Medical Applications. 1st ed. Academic Press; 1995 http://linkinghub.elsevier.com/retrieve/pii/B9780125521109X50004</ref>. Thanks to its highly flexible structure, and the presence of several binding sites that are able to accommodate a variety of small molecules, SA is also the major facilitator of vascular drug transport. Up to now, ten binding sites within albumin have been characterized as drug sites, and nine of these have been demonstrated to bind at least three FDA-approved drugs<ref name='Handing'>doi: 10.1021/acs.jmedchem.0c00225</ref>. Due to the high degree of structural conservation between mammalian albumins, non-human albumins, such as bovine serum albumin, or animal models, are often used to understand human albumin-drug interactions.
 +
 +
The results reported herein provide insight into the circulatory transport of ketoprofen, a popular nonsteroidal anti-inflammatory drug (NSAID), across species. The structure of the ketoprofen complex with human SA revealed that four ketoprofen molecules bind to three distinct sites within SA, which only partially overlap with sites previously reported to bind ketoprofen in SAs from other species.
 +
 +
<scene name='94/949060/Cv/4'>The overall structure of Human SA complex with ketoprofen</scene>. <span class="bg-yellow"><span class="far fa-hand-point-right"></span> Remember to drag the structures with the mouse to rotate them.</span> Albumin subdomains are each shown in a different color. Roman numerals (I, II, III) are associated with domains and letters (''e.g.,'' IB) with subdomains. Ketoprofen molecules are shown with atoms in white spheres.
 +
 +
Ketoprofen binding sites in HSA (PDB ID: [[7jwn]]):
 +
*<scene name='94/949060/Cv/9'>Drug site 2; (S)-ketoprofen</scene>.
 +
*<scene name='94/949060/Cv/6'>Drug site 3; 2 molecules of (S)-ketoprofen</scene>.
 +
*<scene name='94/949060/Cv/8'>Drug site 9; (R)-ketoprofen</scene>.
 +
 +
<scene name='94/949060/Cv/10'>Comparison of (S)-ketoprofen binding to drug site 2</scene> in HSA (PDB ID: [[7jwn]]) and LSA (PDB ID: [[6ock]]). (S)-Ketoprofen molecule and molecule of a fatty acid bound to HSA are shown in stick representation with oxygen
 +
atoms in red and carbon atoms in yellow, while a molecule of (S)-ketoprofen bound to LSA is shown in stick representation with oxygen atoms in red and carbon atoms in gray.
 +
 +
Superposition of structure of the HSA-ketoprofen complex (PDB ID: [[7jwn]]; cartoon shown in gray) with the following complexes:
 +
*<scene name='94/949060/Cv/11'>ESA-ketoprofen</scene> (PDB ID: [[6u4r]]).
 +
*<scene name='94/949060/Cv/13'>BSA-ketoprofen</scene> (PDB ID: [[6qs9]]).
 +
*<scene name='94/949060/Cv/14'>LSA-ketoprofen</scene> (PDB ID: [[6ock]]).
 +
*<scene name='94/949060/Cv/15'>HSA-ligand free</scene> (PDB ID: [[4k2c]]).
 +
*<scene name='94/949060/Cv/16'>HSA-myristic acid</scene> (PDB ID: [[1bj5]]).
 +
 +
We explored the reasons for the observed differences, including identifying residues and interactions required for ketoprofen binding at specific sites and the influence of metabolites and components of crystallization solution on drug binding. The presented results reveal that the drug-binding properties of albumins cannot be easily predicted based only on a complex of albumin from another organism and the conservation of drug sites between species. This work shows that understanding organism-dependent differences is essential for assessing the suitability of particular albumins for structural or biochemical studies.
<b>References</b><br>
<b>References</b><br>

Current revision

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky, Jaime Prilusky

This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.
Personal tools